Colon-delivered multivitamin supplementation enhances working memory-related fMRI responses in older adults: a randomized, placebo-controlled trial

In a randomized, placebo-controlled trial, colon-delivered multivitamin supplementation enhanced working memory-related fMRI responses in the hippocampus and dorsolateral prefrontal cortex of older adults at risk of cognitive decline, although it did not significantly alter fecal short-chain fatty acid levels or behavioral performance, while changes in short-chain fatty acids were positively correlated with improvements in brain activity and cognitive function across both groups.

The Gist

The Big Picture: A "Gut-Brain" Tune-Up

Imagine your body is a high-tech city. The gut is the power plant and recycling center, while the brain is the city's command center (the mayor's office). For a long time, scientists thought these two operated in separate buildings. But we now know they are connected by a super-high-speed fiber-optic cable called the Gut-Brain Axis.

This study asked a simple question: If we send a "maintenance crew" (vitamins) directly to the power plant (the gut), will the command center (the brain) run better?

Specifically, the researchers wanted to know if giving older adults a special vitamin supplement that dissolves only in the colon (the very end of the gut) could improve their memory and change how their brain works.

The Experiment: The "Magic Capsule" vs. The "Sugar Pill"

The Participants:
The study recruited 75 older adults (ages 60–75) who had some lifestyle risk factors for memory loss, like being overweight or not exercising enough. Think of them as drivers whose cars are starting to show a little wear and tear.

The Intervention:
For six weeks, half the group took a Colon-Delivered Multivitamin (CDMV).

• The Trick: These weren't normal pills. They were coated in a special "magic shell" (Eudragit) that survives the stomach and small intestine. It only breaks open when it reaches the colon (the large intestine).
• The Cargo: Inside were vitamins B2, B3, B6, B9, C, and D3.
• The Goal: The researchers hoped these vitamins would act like fertilizer for the "good bacteria" living in the colon, helping them produce Short-Chain Fatty Acids (SCFAs). Think of SCFAs as the "clean energy" or "fuel" that bacteria make when they digest fiber, which then travels up the fiber-optic cable to the brain to keep it sharp.

The other half took a placebo (a fake pill with no vitamins), acting as the control group.

The Results: What Happened?

The researchers checked three main things:

1. The Fuel (SCFAs): Did the bacteria produce more clean energy?
2. The Performance: Did the participants get better at memory tests?
3. The Brain Activity: Did the brain's "engine" rev up differently during memory tasks?

Here is what they found:

1. The Fuel Tank Didn't Fill Up (Surprise!)

The Result: The group taking the vitamins did not have higher levels of SCFAs (the "clean energy") in their poop compared to the placebo group.
The Analogy: It was like giving the power plant a new delivery of raw materials, but the workers (bacteria) didn't seem to produce more electricity than usual.
Why? The researchers suspect that while the vitamins arrived, the bacteria might have needed more "food" (fermentable fiber) to really get going, or the specific mix of vitamins didn't trigger the reaction they hoped for in older adults.

2. The Drivers Didn't Drive Faster (No Performance Change)

The Result: When the participants took memory tests (like a "n-back" game where you have to remember numbers), their scores didn't improve significantly compared to the placebo group.
The Analogy: The drivers didn't finish the race any faster.

3. The Engine Revved Up (The Big Discovery!)

The Result: Even though the drivers didn't go faster, the brain scans told a different story. The brains of the vitamin group showed increased activity in two key areas:

• The dlPFC (The CEO's Desk): The part of the brain responsible for focus and working memory.
• The Hippocampus (The Librarian): The part responsible for storing and retrieving memories.
  The Analogy: Imagine a car that isn't driving faster yet, but the engine is humming more efficiently. The brain was working harder or more efficiently to do the same task. It was "recruiting" more brain power to get the job done.

The "Aha!" Moment: The Connection

Here is the most fascinating part of the study. Even though the vitamin group didn't as a whole produce more SCFAs, the researchers looked at individual changes.

They found that for anyone (whether they took vitamins or the placebo) whose gut bacteria did manage to produce a little more SCFA, their brain activity and memory performance improved.

The Metaphor:
Think of the gut bacteria as a garden. The vitamins were like a new type of fertilizer.

• The fertilizer didn't make the whole garden bloom instantly.
• BUT, in the specific spots where the fertilizer did help the plants grow a little more (more SCFAs), the "signal" to the brain (the city) got stronger, and the brain's memory center woke up.

The Takeaway

Did the vitamins work?
Yes and no.

• No: They didn't magically boost memory scores or flood the gut with energy fuel in this specific 6-week trial.
• Yes: They changed how the brain works. The brain became more active in the areas needed for memory. This suggests the gut-brain connection is real and responsive, even in older adults.

What's Next?
The researchers suggest that maybe the "magic shell" needs to be tweaked, or maybe the vitamins need to be paired with a diet high in specific fibers to really get the bacteria working. It's like realizing that giving a car a new spark plug is great, but you also need to put the right kind of gas in the tank to see the full speed boost.

In short: Sending vitamins to the gut can wake up the brain's memory centers, even if it doesn't immediately make you smarter. It's a promising first step in understanding how feeding our gut bacteria might help keep our minds sharp as we age.

Technical Summary

1. Problem Statement

The study addresses the emerging role of the gut-brain axis in cognitive aging. While age-related changes in the gut microbiome and reduced levels of microbial metabolites (specifically Short-Chain Fatty Acids or SCFAs) are linked to cognitive decline, causal evidence and neurocognitive mechanisms remain poorly understood.

• Gap: Most dietary vitamins are absorbed in the small intestine, preventing them from reaching the colon where they could modulate the microbiome.
• Hypothesis: Delivering a multivitamin formulation directly to the colon (Colon-Delivered Multivitamin or CDMV) could act as a prebiotic-like intervention, stimulating microbial SCFA production and subsequently improving neurocognitive function (specifically Working Memory) in older adults at risk of cognitive decline.

2. Methodology

Study Design:

• Type: Double-blind, randomized, placebo-controlled trial (RCT).
• Participants: 75 Dutch adults aged 60–75 years with lifestyle-related risk factors for cognitive decline (e.g., BMI ≥25, physical inactivity, type 2 diabetes, hypertension). 67 participants completed the study (31 CDMV, 36 Placebo).
• Intervention: Daily consumption of a colon-targeted capsule for 6 weeks.
  • CDMV Group: Contained Vitamins B2, B3, B6, B9, C, and D3, encapsulated in an Eudragit S 100 coating to ensure release in the colon (pH >7).
  • Placebo Group: Identical capsules containing microcrystalline cellulose and magnesium stearate.

Primary Outcomes:

1. Intestinal Health: Fecal concentrations of SCFAs (acetate, propionate, butyrate, valerate).
2. Neurocognition (fMRI): Working Memory (WM)-related Blood-Oxygen-Level-Dependent (BOLD) responses in the Dorsolateral Prefrontal Cortex (dlPFC) and Hippocampus during an n-back task (0-back, 1-back, 2-back).
3. Neurocognition (Behavioral): WM performance measured by d-prime ($d'$) on the n-back task.

Secondary Outcomes:

• Fecal microbiota composition (16S rRNA sequencing).
• Blood biomarkers (vitamin levels, systemic inflammation, intestinal permeability).
• Cerebral blood flow (ASL) and neuroinflammatory metabolites (1H-MRS).
• Psychometric tests (executive function, episodic memory, stress/anxiety).

Data Analysis:

• fMRI: Preprocessed using fMRIPrep and analyzed in SPM12. Primary analysis focused on the 2-back minus 0-back contrast. Region-of-Interest (ROI) analysis was conducted on the dlPFC and hippocampus.
• Statistics: Linear models adjusted for baseline values, age, sex, education, and dietary fiber. Correlations between changes ($\Delta$ post-pre) in gut and brain metrics were assessed using Spearman's rank correlation.

3. Key Contributions

• First Human Neuroimaging Trial: This is the first study to investigate the effects of a colon-targeted multivitamin intervention on task-based fMRI responses in older adults.
• Mechanistic Insight: It provides evidence for the gut-brain axis by correlating within-subject changes in fecal SCFAs with changes in brain activation and cognitive performance, independent of the intervention group.
• Targeted Delivery Validation: It validates the feasibility of colon-targeted vitamin delivery in an older population, despite mixed results on the primary gut outcome (SCFAs).

4. Results

Intestinal and Microbiome Outcomes:

• SCFAs: No significant between-group difference was found in total fecal SCFA levels or individual SCFAs (p=0.30).
• Microbiota: While overall alpha/beta diversity did not change, three specific genera increased significantly in the CDMV group: Lachnospiraceae FCS020, Eubacterium ventriosum, and Ruminococcus gauvreauii (all known SCFA producers).
• Other Markers: Fecal hexanoic acid (a medium-chain fatty acid) increased in the CDMV group. No significant changes were observed in systemic inflammation or blood SCFAs.

Neurocognitive Outcomes:

• Behavioral Performance: No significant difference in working memory performance ($d'$) between groups (p=0.50).
• fMRI Responses (Brain Activation):
  • Hippocampus: Significantly higher WM-related BOLD responses in the CDMV group compared to placebo (p=0.01; $\eta_p^2$=0.09).
  • dlPFC: Marginally significant increase in the CDMV group (p=0.06), driven primarily by the right dlPFC (p=0.02).
  • Connectivity: Functional connectivity (gPPI) between the dlPFC and hippocampus was significantly higher in the CDMV group (p=0.03).
• Blood Vitamins: Only Vitamin B6 showed significant systemic elevation in the CDMV group, suggesting partial colonic absorption; this was controlled for in the analysis.

Gut-Brain Correlations:

• Crucially, across both groups, increases in fecal SCFAs were positively correlated with increases in:
  • WM-related dlPFC fMRI responses ($\rho$=0.31, p=0.02).
  • WM behavioral performance ($\rho$=0.43, p=0.001).
• This suggests a direct link between SCFA production and cognitive function, regardless of whether the SCFA increase was driven by the supplement or other factors.

5. Significance and Conclusion

• Neural Modulation: A 6-week colon-delivered multivitamin intervention can modulate neural recruitment in brain regions critical for working memory (dlPFC and hippocampus) in older adults, even in the absence of measurable behavioral improvements or significant changes in total fecal SCFAs.
• Interpretation of Activation: The increased fMRI response could represent either a beneficial enhancement of neural efficiency or a compensatory mechanism to maintain performance. The positive correlation between SCFA increases and both brain activation and performance suggests the former (beneficial).
• Limitations & Future Directions: The lack of SCFA increase may be due to the specific vitamin combination, the 6-week duration, or insufficient fermentable fiber substrate in the diet. The study recommends future trials to:
  • Optimize vitamin formulations (e.g., including Vitamin B1).
  • Extend intervention duration to 12 weeks.
  • Combine vitamins with prebiotic fibers.
  • Use advanced techniques (smart capsules, direct colonic sampling) to better map gut-brain mechanisms.

Conclusion: The study demonstrates that colon-delivered multivitamins can enhance neurocognitive brain responses in older adults, providing human evidence for the gut-brain axis's role in cognitive aging, though the specific peripheral mediators (beyond SCFA correlations) require further elucidation.